217 related articles for article (PubMed ID: 8083238)
1. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria.
Wolucka BA; McNeil MR; de Hoffmann E; Chojnacki T; Brennan PJ
J Biol Chem; 1994 Sep; 269(37):23328-35. PubMed ID: 8083238
[TBL] [Abstract][Full Text] [Related]
2. The presence of beta-D-ribosyl-1-monophosphodecaprenol in mycobacteria.
Wolucka BA; de Hoffmann E
J Biol Chem; 1995 Aug; 270(34):20151-5. PubMed ID: 7650033
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy.
Wolucka BA
FEBS J; 2008 Jun; 275(11):2691-711. PubMed ID: 18422659
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis.
Takayama K; Kilburn JO
Antimicrob Agents Chemother; 1989 Sep; 33(9):1493-9. PubMed ID: 2817850
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of the major form of polyprenyl-phospho-mannose from Mycobacterium smegmatis.
Wolucka BA; de Hoffmann E
Glycobiology; 1998 Oct; 8(10):955-62. PubMed ID: 9719676
[TBL] [Abstract][Full Text] [Related]
6. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.
Silve G; Valero-Guillen P; Quemard A; Dupont MA; Daffe M; Laneelle G
Antimicrob Agents Chemother; 1993 Jul; 37(7):1536-8. PubMed ID: 8363387
[TBL] [Abstract][Full Text] [Related]
7. Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d-arabinose synthesis.
Huang H; Scherman MS; D'Haeze W; Vereecke D; Holsters M; Crick DC; McNeil MR
J Biol Chem; 2005 Jul; 280(26):24539-43. PubMed ID: 15878857
[TBL] [Abstract][Full Text] [Related]
8. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.
Mikusová K; Slayden RA; Besra GS; Brennan PJ
Antimicrob Agents Chemother; 1995 Nov; 39(11):2484-9. PubMed ID: 8585730
[TBL] [Abstract][Full Text] [Related]
9. GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis.
Kolly GS; Mukherjee R; Kilacsková E; Abriata LA; Raccaud M; Blaško J; Sala C; Dal Peraro M; Mikušová K; Cole ST
J Bacteriol; 2015 Dec; 197(23):3686-97. PubMed ID: 26369580
[TBL] [Abstract][Full Text] [Related]
10. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.
Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239
[TBL] [Abstract][Full Text] [Related]
11. Functional identification of MSMEG_6402 protein from Mycobacterium smegmatis in decaprenylphosphoryl-D-arabinose biosynthesis.
Jiang T; Cai L; Zhao X; He L; Ma Y; Zang S; Zhang C; Li X; Xin Y
Microb Pathog; 2014 Nov; 76():44-50. PubMed ID: 25223716
[TBL] [Abstract][Full Text] [Related]
12. The composition of cell wall skeleton and outermost lipids of Mycobacterium vaccae is modified by ethambutol treatment.
Rumijowska-Galewicz A; Korycka-Machała M; Lisowska K; Dziadek J
Pol J Microbiol; 2008; 57(2):99-104. PubMed ID: 18646396
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of sugar nucleotides from Mycobacterium smegmatis.
Singh S; Hogan SE
Microbios; 1994; 77(313):217-22. PubMed ID: 8208136
[TBL] [Abstract][Full Text] [Related]
14. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol.
Khoo KH; Douglas E; Azadi P; Inamine JM; Besra GS; Mikusová K; Brennan PJ; Chatterjee D
J Biol Chem; 1996 Nov; 271(45):28682-90. PubMed ID: 8910503
[TBL] [Abstract][Full Text] [Related]
15. Arabinan-deficient mutants of Corynebacterium glutamicum and the consequent flux in decaprenylmonophosphoryl-D-arabinose metabolism.
Alderwick LJ; Dover LG; Seidel M; Gande R; Sahm H; Eggeling L; Besra GS
Glycobiology; 2006 Nov; 16(11):1073-81. PubMed ID: 16891347
[TBL] [Abstract][Full Text] [Related]
16. Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability.
Shi L; Zhou R; Liu Z; Lowary TL; Seeberger PH; Stocker BL; Crick DC; Khoo KH; Chatterjee D
J Bacteriol; 2008 Aug; 190(15):5248-55. PubMed ID: 18556798
[TBL] [Abstract][Full Text] [Related]
17. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan.
Escuyer VE; Lety MA; Torrelles JB; Khoo KH; Tang JB; Rithner CD; Frehel C; McNeil MR; Brennan PJ; Chatterjee D
J Biol Chem; 2001 Dec; 276(52):48854-62. PubMed ID: 11677227
[TBL] [Abstract][Full Text] [Related]
18. Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species.
Misaki A; Azuma I; Yamamura Y
J Biochem; 1977 Dec; 82(6):1759-70. PubMed ID: 413830
[TBL] [Abstract][Full Text] [Related]
19. Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed.
Lee RE; Li W; Chatterjee D; Lee RE
Glycobiology; 2005 Feb; 15(2):139-51. PubMed ID: 15371346
[TBL] [Abstract][Full Text] [Related]
20. Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses.
Daffe M; Brennan PJ; McNeil M
J Biol Chem; 1990 Apr; 265(12):6734-43. PubMed ID: 2108960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
